A Combination Study of Durvalumab plus Olaparib in an Unselected Population with Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

reportActive / Technical Report | Accesssion Number: AD1190938 | Open PDF

Abstract:

No Abstract Identified

Author(s):
Karzai, Fatima
Author Organization(s):
GENEVA FOUNDATION TACOMA WA
Funding Organization(s):
ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND FORT DETRICK MD, FORT DETRICK , MD
Document Type:
Technical Report/Annual Report
Publication Date:
2022 Aug 01
Pagination:
15

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution Code:
A - Approved For Public Release
Distribution Statement: Public Release

RECORD

Collection: TRECMS
Subject Terms
Communities of Interest:
No COI(s) Identified
Descriptor(s):
medical personnel, prostate cancer, blood, clinical trials, covid-19, neoplasms, biomedical research, lymphocytes, cancer, cells, professional development, prostate, therapy, availability, immunotherapy, instructions, management personnel
Creation Date:
2023 Jan 25
Update Date:
2023 Jan 25